Inventors
Katharina Bergerhoff, Oxana Polyakova, Oliver Nussbaumer
Assignees
GammaDelta Therapeutics
Abstract
The invention relates to ex vivo methods of modulating Vδ1 T cells using anti-Vδ1 antibodies or fragments thereof.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.